🇺🇸 FDA
Pipeline program

mitoxantrone liposome 16 and azacitidine

MitAITL

Phase 2 small_molecule active

Quick answer

mitoxantrone liposome 16 and azacitidine for Angioimmunoblastic T-cell Lymphoma is a Phase 2 program (small_molecule) at NovaBridge Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
NovaBridge Biosciences
Indication
Angioimmunoblastic T-cell Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials